Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Quality Index
Jilin Aodong Pharmaceutical Group Co Ltd cash flow quality index. Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Quality Index of 0.11x as of September 2025. Operating cash flow of CN¥112.12 Million is below net income of CN¥978.96 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Jilin Aodong Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)
Cash flow quality index of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Jilin Aodong Pharmaceutical Group Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jilin Aodong Pharmaceutical Group Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (1998–2025)
Jilin Aodong Pharmaceutical Group Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Jilin Aodong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥272.26 Million | CN¥2.40 Billion | ▲ +190.3% |
| 2024 | 0.04x | CN¥59.48 Million | CN¥1.52 Billion | ▼ -16.0% |
| 2023 | 0.05x | CN¥68.06 Million | CN¥1.46 Billion | ▼ -80.4% |
| 2022 | 0.24x | CN¥423.86 Million | CN¥1.78 Billion | ▲ +30.5% |
| 2021 | 0.18x | CN¥324.85 Million | CN¥1.78 Billion | ▼ -20.1% |
| 2020 | 0.23x | CN¥390.41 Million | CN¥1.71 Billion | ▼ -16.1% |
| 2019 | 0.27x | CN¥379.46 Million | CN¥1.39 Billion | ▼ -26.7% |
| 2018 | 0.37x | CN¥347.64 Million | CN¥935.19 Million | ▲ +167.4% |
| 2017 | 0.14x | CN¥256.49 Million | CN¥1.85 Billion | ▼ -30.6% |
| 2016 | 0.20x | CN¥333.81 Million | CN¥1.67 Billion | ▲ +34.3% |
| 2015 | 0.15x | CN¥388.03 Million | CN¥2.60 Billion | ▼ -26.8% |
| 2014 | 0.20x | CN¥288.83 Million | CN¥1.42 Billion | ▲ +7.5% |
| 2013 | 0.19x | CN¥201.22 Million | CN¥1.06 Billion | ▼ -54.8% |
| 2012 | 0.42x | CN¥272.40 Million | CN¥649.87 Million | ▲ +667.5% |
| 2011 | 0.05x | CN¥108.30 Million | CN¥1.98 Billion | ▼ -60.6% |
| 2010 | 0.14x | CN¥174.22 Million | CN¥1.26 Billion | ▼ -9.7% |
| 2009 | 0.15x | CN¥213.03 Million | CN¥1.39 Billion | ▼ -42.0% |
| 2008 | 0.27x | CN¥235.03 Million | CN¥886.21 Million | ▲ +38.0% |
| 2007 | 0.19x | CN¥384.69 Million | CN¥2.00 Billion | ▼ -59.2% |
| 2006 | 0.47x | CN¥187.99 Million | CN¥399.47 Million | ▼ -53.8% |
| 2005 | 1.02x | CN¥136.26 Million | CN¥133.76 Million | ▼ -27.7% |
| 2004 | 1.41x | CN¥218.53 Million | CN¥155.11 Million | ▲ +15.1% |
| 2003 | 1.22x | CN¥147.65 Million | CN¥120.67 Million | ▲ +2472.1% |
| 2002 | -0.05x | CN¥-4.58 Million | CN¥88.71 Million | ▼ -103.1% |
| 2001 | 1.69x | CN¥138.76 Million | CN¥82.07 Million | ▲ +91.8% |
| 2000 | 0.88x | CN¥77.04 Million | CN¥87.40 Million | ▼ -19.7% |
| 1999 | 1.10x | CN¥110.18 Million | CN¥100.32 Million | ▲ +419.3% |
| 1998 | -0.34x | CN¥-30.90 Million | CN¥89.82 Million | — |